Obsessive Compulsive Disorder (OCD) is a serious psychiatric condition that often does not respond to standard treatments. Serotonin is thought to be involved in reducing OCD symptoms. A case is presented of a person who used psilocybin, a substance that affects serotonin, to successfully reduce core OCD symptoms for several years. The authors do not endorse this form of treatment but argue that the positive outcome highlights the role of serotonin in OCD and supports the need for legitimate research into psilocybin for anxiety disorders.
Former users of alpha-methyltryptamine (AMT) reported that the drug has strong hallucinogenic effects. The most common unwanted side effects included anxiety, nausea, and moderately severe dysphoria. Several users also experienced significant depression, suggesting that AMT use could be dangerous for individuals prone to depression.